MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-11-30.

Income Overview

Net Income
-$1,600.751K
EPS
-$0.07
Unit: Thousand (K) dollars

Income Statement
2025-11-30
2025-08-31
Revenue
0 177*
Cost of goods sold
0 1*
Gross profit
0 176*
Research and development
671.34 2,059*
General and administrative
902.291 1,086*
Total operating expenses
1,573.631 3,145*
Loss from operations
-1,573.631 -2,969*
Interest income
0.012 1*
Unrealized loss on marketable securities
-22.093 -9*
Total other income (loss)
-22.081 -8*
Net loss before income taxes
-1,595.712 -
Income taxes
1.791 -
Net loss
-1,597.503 -2,977*
Less net loss attributable to non-controlling interest
-2.496 -2*
Net loss attributable to lexaria shareholders
-1,595.007 -2,975*
Foreign currency translation adjustment
-5.744 -13*
Total comprehensive loss
-1,600.751 -2,988
Diluted EPS
-0.07 -0.166
Diluted Average Shares
21,376,029 17,998,715
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Total comprehensiveloss-$1,600.751K Net lossattributable to lexaria...-$1,595.007K Foreign currencytranslation adjustment-$5.744K Less net lossattributable to...-$2.496K Net loss-$1,597.503K Net loss beforeincome taxes-$1,595.712K Income taxes$1.791K Loss from operations-$1,573.631K Total other income(loss)-$22.081K Interest income$0.012K Total operatingexpenses$1,573.631K Unrealized loss onmarketable securities-$22.093K General andadministrative$902.291K Research and development$671.34K

Lexaria Bioscience Corp. (LEXXW)

Lexaria Bioscience Corp. (LEXXW)